Integrated Filing-Governance



General information about company

Scrip Code 531349
NSE Symbol PANACEABIO
MSEI Symbol NOTLISTED
ISIN INE922B01023
Name of the entity Panacea Biotec Limited
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Reporting Quarter Yearly
Date of Quarter Ending 31-Mar-2026
Type of company Equity
Whether Annexure I (Part A) of the SEBI Circular dated December 31, 2024 related to Compliance Report on Corporate Governance is applicable to the entity? Yes
Whether Annexure I (Part B) of the SEBI Circular dated December 31, 2024 related to Investor Grievance Redressal Report is Applicable to the entity? Yes
Whether Annexure I (Part C) of the SEBI Circular dated December 31, 2024 related to Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies is Applicable to the entity? No
Reason For Part C Of Annexure I Disclosure Of Acquisition Of Shares OrVotingRightsInUnlistedCompaniesIsNotApplicableToTheEntity No shares or voting rights of an unlisted company has been acquired by the Company during the quarter ended March 31, 2026, in terms of sub-para 1 of Para A of Part A of Schedule III of SEBI LODR Regulations, 2015
Whether Annexure I (Part D) of the SEBI Circular dated December 31, 2024 related to Disclosure of Imposition of Fine or Penalty is Applicable to the entity? No
Reason For Part D Of Annexure I Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity There is no imposition of fine or penalty during the quarter ended March 31, 2026, in terms of sub-para 20 of para A of Part A of Schedule III of SEBI LODR Regulations, 2015
Whether Annexure I (Part E) of the SEBI Circular dated December 31, 2024 related to Disclosure of Updates to Ongoing Tax Litigations or Disputes is Applicable to the entity? Yes
Whether Annexure I (Part F) of the SEBI Circular dated December 31, 2024 related to Disclosure Of Loans / Guarantees / Comfort Letters / Securities Etc. is Applicable to the entity? No
Reason For Part F Of Annexure I Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity No - Save and except the loans (or other form of debt) covered under the exclusions provided in SEBI Circular No. SEBI/HO/CFD/CMD-2/P/CIR/2021/567 dated May 31, 2021, the Company has not given any loan (or other form of debt), guarantee / comfort letter (by whatever name called) or provided security in connection with any loan or any other form of debt. Hence, the additional half yearly disclosure is not applicable on the Company.
Risk management committee Yes
Market Capitalisation as per immediate previous Financial Year Top 2000 listed entities
Is SCORE ID Available ? Yes
SCORE Registration ID p00021
Reason For No SCORE ID
Type of Submission New
Remarks (website dissemination)



Annexure I
Annexure I to be submitted by listed entity on quarterly basis
I. Composition of Board of Directors
Disclosure of notes on composition of board of directors explanatory Note: Pursuant to Regulation 26 of the SEBI LODR Regulations, Chairmanship in Committees of all listed entities and Membership in Committees of all public limited companies, whether listed or not, is taken into consideration and all other companies including private limited companies, foreign companies, high value debt listed entities and companies under Section 8 of the Companies Act, 2013 have been excluded.
Whether the listed entity has a Regular Chairperson Yes
Whether Chairperson is related to MD or CEO Yes Disqualification of Directors under section 164 of the Companies Act, 2013
Sr Title (Mr / Ms) Name of the Director PAN DIN Category 1 of directors Category 2 of directors Category 3 of directors Date of Birth Whether the director is disqualified? Start Date of disqualification End Date of disqualification Details of disqualification Current status Whether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations] Date of passing special resolution Initial Date of appointment Date of Re-appointment Date of cessation Tenure of director (in months) No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations) No of Independent Directorship in listed entities including this listed entity [with reference to proviso to regulation 17A(1) & 17A(2)] Number of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations) No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations) Reason for Cessation Notes for not providing PAN Notes for not providing DIN
1 Mr. Rajesh Jain 00013053 Executive Director Chairperson MD 26-Apr-1964 No Active NA 15-Nov-1984 01-Jan-2025 1 0 0 0
2 Mr. Sandeep Jain 00012973 Executive Director Not Applicable 17-Jul-1966 No Active NA 15-Nov-1984 01-Apr-2025 1 0 1 0
3 Mr. Ankesh Jain 03556647 Executive Director Not Applicable 08-Jun-1988 No Active NA 01-Apr-2016 01-Apr-2025 1 0 1 0
4 Mr. Harshet Jain 08732974 Executive Director Not Applicable 26-Aug-1992 No Active NA 14-Feb-2025 14-Feb-2025 1 0 0 0
5 Mr. Sanjay Trehan 10936402 Executive Director Not Applicable 24-Feb-1959 No Active NA 14-Feb-2025 14-Feb-2025 1 0 1 0
6 Mr. Mukul Gupta 00254597 Non-Executive - Independent Director Not Applicable 16-Aug-1957 No Active NA 01-Apr-2016 01-Apr-2021 31-Mar-2026 120 1 1 1 1 Tenure Completion
7 Mrs. Ambika Sharma 08201798 Non-Executive - Independent Director Not Applicable 16-Jun-1962 No Active NA 14-Feb-2024 14-Feb-2024 25.18 6 6 10 2
8 Mr. Rajesh Jain 10619014 Non-Executive - Independent Director Not Applicable 13-Feb-1955 No Active NA 13-Nov-2024 13-Nov-2024 16.19 3 3 7 3
9 Mr. Krishan Kumar Jalan 01767702 Non-Executive - Independent Director Not Applicable 06-Jun-1957 No Active NA 14-Feb-2025 14-Feb-2025 13.18 5 5 8 3
10 Mr. Rajender Pal Singh 10198810 Non-Executive - Independent Director Not Applicable 25-Mar-1963 No Active NA 14-Feb-2025 14-Feb-2025 13.18 2 2 0 0
11 Mr. Venkatesh Sarvasiddhi 09326552 Non-Executive - Independent Director Not Applicable 25-Sep-1980 No Active NA 14-Feb-2025 14-Feb-2025 13.18 1 1 0 0



Annexure 1

II. Composition of Committees
Disclosure of notes on composition of committees explanatory Audit Committee has been reconstituted w.e.f. 31.03.2026. CA Rajesh Jain has been appointed as Chairman of the Audit Committee w.e.f. 31.03.2026..Note: 1. Audit Committee, Nomination & Remuneration Committee and Risk Management Committee have been reconstituted w.e.f. 31.03.2026. CA Rajesh Jain has been appointed as Chairman of the Audit Committee w.e.f. 31.03.2026. 2. The Committees which are mandatory under the SEBI LODR Regulations, 2015 and Companies Act, 2013, have only been considered for reporting under this Section. Accordingly, the details of other committees viz. Global Expansion Project Management Committee, Dubai Advance Settlement Committee and ERP System Assessment Committee have not been included.



Audit Committee Details
Whether the Audit Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 00254597 Mukul Gupta Non-Executive - Independent Director Chairperson 01-Apr-2024 31-Mar-2026
2 10619014 Rajesh Jain Non-Executive - Independent Director Chairperson 14-Nov-2024 Textual Information(1)
3 08201798 Ambika Sharma Non-Executive - Independent Director Member 01-Apr-2024
4 01767702 Krishan Kumar Jalan Non-Executive - Independent Director Member 31-Mar-2026



Text Block
Textual Information(1) Audit Committee has been reconstituted w.e.f. 31.03.2026. CA Rajesh Jain has been appointed as Chairman of the Audit Committee w.e.f. 31.03.2026



Nomination and remuneration committee
Whether the Nomination and remuneration committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 08201798 Ambika Sharma Non-Executive - Independent Director Chairperson 29-Mar-2025
2 00254597 Mukul Gupta Non-Executive - Independent Director Member 01-Apr-2024 31-Mar-2026
3 10619014 Rajesh Jain Non-Executive - Independent Director Member 14-Nov-2024
4 10198810 Rajender Pal Singh Non-Executive - Independent Director Member 31-Mar-2026



Stakeholders Relationship Committee
Whether the Stakeholders Relationship Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 08201798 Ambika Sharma Non-Executive - Independent Director Chairperson 29-Mar-2025
2 10936402 Sanjay Trehan Executive Director Member 29-Mar-2025
3 00012973 Sandeep Jain Executive Director Member 31-Oct-2014



Risk Management Committee
Whether the Risk Management Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 00013053 Rajesh Jain ED Chairperson 23-Jul-2021
2 00012973 Sandeep Jain ED Member 23-Jul-2021
3 03556647 Ankesh Jain ED Member 01-Apr-2024
4 00254597 Mukul Gupta ID Member 01-Apr-2024 31-Mar-2026
5 10936402 Sanjay Trehan ED Member 29-Mar-2025
6 10619014 Rajesh Jain ID Member 31-Mar-2026
7 10198810 Rajender Pal Singh ID Member 31-Mar-2026



Annexure 1
III. Meeting of Board of Directors
Disclosure of notes on meeting of board of directors explanatory
Sr Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) Maximum gap between any two consecutive (in number of days) Notes for not providing Date Whether requirement of Quorum met (Yes/No) Total Number of Directors as on date of the meeting Number of Directors present* (All directors including Independent Director) No. of Independent Directors attending the meeting*
1 14-Nov-2025 Yes 11 10 6
2 15-Dec-2025 30 Yes 11 10 6
3 11-Feb-2026 57 Yes 11 11 6



Annexure 1
IV. Meeting of Committees
Disclosure of notes on meeting of committees explanatory
Sr Name of Committee Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) Maximum gap between any two consecutive (in number of days) Name of other committee Reson for not providing date Whether requirement of Quorum met (Yes/No) Total Number of Directors in the Committee as on date of the meeting Number of Directors Present (All Directors including Independent Director) No. of Independent Directors attending the meeting* No. of members attending the meeting (other than Board of Directors)
1 Audit Committee 14-Nov-2025 Yes 3 3 3 0
2 Audit Committee 15-Dec-2025 30 Yes 3 3 3 0
3 Audit Committee 11-Feb-2026 57 Yes 3 3 3 0
4 Nomination and remuneration committee 13-Nov-2025 Yes 3 2 2 0
5 Nomination and remuneration committee 15-Dec-2025 31 Yes 3 3 3 0
6 Stakeholders Relationship Committee 13-Nov-2025 Yes 3 3 1 0
7 Stakeholders Relationship Committee 10-Feb-2026 88 Yes 3 3 1 0
8 Risk Management Committee 13-Nov-2025 Yes 5 2 0 0



Annexure 1
VI. Affirmations
Sr Subject Compliance status (Yes/No)
1 The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015 Yes
2 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit Committee Yes
3 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committee Yes
4 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committee Yes
5 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 1000 listed entities) Yes
6 The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015. Yes
7 The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015 Yes
8 This report and/or the report submitted in the previous quarter has been placed before Board of Directors. Yes
9 Any comments/observations/advice of Board of Directors may be mentioned here: The Corporate Governance Report submitted in the previous quarter was placed before Board of Directors in its meeting held on 11.02.2026. There were no commments/observations/advice in the meeting held on 11.02.2026. This report will be placed in subsequent meeting of the Board of Directors and comments/observations, if any, will be mentioned in subsequent report.



Annexure 1
Sr Subject Compliance status
1 Name of signatory Ankit Jain
2 Designation Company Secretary and Compliance Officer



Details of Cyber security incidence
Whether as per Regulation 27(2)(ba) of SEBI (LODR) Regulations, 2015 there has been cyber security incidents or breaches or loss of data or documents during the quarter No
Other details of cyber security incidence or breaches or loss of data event
Number of cyber security incidence or breaches or loss of data event occurred during the quarter
Sr Date of the event Brief details of the event



Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)
I. Disclosure on website in terms of LODR Regulation
Sr Item Compliance status (Yes/No/NA) If status is No details of non-compliance may be given here. Web address
1.1 Details of business Yes https://www.panaceabiotec.com/en/content/about-panacea-biotec
1.2 Memorandum of Association and Articles of Association Yes https://media.panaceabiotec.com/other-important-information/2022/Memorandum%20and%20Articles%20of%20association.pdf
1.3 Brief profile of board of directors including directorship and full time positions in body corporates Yes https://www.panaceabiotec.com/en/content/leadership-team
2 Terms and conditions of appointment of independent directors Yes https://media.panaceabiotec.com/policy/2018/tandcappointmentindependentdirectors.pdf
3 Composition of various committees of board of directors Yes https://www.panaceabiotec.com/en/content/about-panacea-biotec/board-committees
4 Code of conduct of board of directors and senior management personnel Yes https://media.panaceabiotec.com/policy/2025/code-of-conduct-for-board-and-senior-management.pdf
5 Details of establishment of vigil mechanism or whistle blower policy Yes https://media.panaceabiotec.com/policy/2019/Vigil_Mechanism_Policy.pdf
6 Criteria of making payments to non-executive directors Yes https://media.panaceabiotec.com/policy/2022/criteriaofmakingpaymenttononexecutivedirectors.pdf
7 Policy on dealing with related party transactions Yes https://media.panaceabiotec.com/policy/2025/policy-on-materiality-of-rpt-and-on-dealing-with-rpt.pdf
8 Policy for determining material subsidiaries Yes https://media.panaceabiotec.com/policy/2025/policy-for-determining-material-subsidiaries.pdf
9 Details of familiarization programmes imparted to independent directors Yes https://www.panaceabiotec.com/en/section/information-repository/familiarization-programmes
10 Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances Yes https://media.panaceabiotec.com/other-important-information/2025/Investorscontact.pdf
11 Email address for grievance redressal and other relevant details Yes https://media.panaceabiotec.com/other-important-information/2025/Investorscontact.pdf
12 Financial results Yes https://www.panaceabiotec.com/en/section/information-repository/quarterly-results
13 Shareholding pattern Yes https://www.panaceabiotec.com/en/section/information-repository/shareholding-pattern
14 Details of agreements entered into with the media companies and/or their associates NA
15.1 Schedule of analyst or institutional investor meet and presentation prepared by listed entity for analyst or institutional investor meet Yes https://www.panaceabiotec.com/en/section/information-repository/corporate-presentation
15.2 Audio or video recordings and transcripts of post earnings/quarterly calls NA
16 New name and the old name of the listed entity NA
17 Advertisements as per regulation 47 (1) Yes https://www.panaceabiotec.com/en/section/information-repository/newspaper-publications
18 Credit rating or revision in credit rating obtained Yes https://www.panaceabiotec.com/en/section/information-repository/credit-rating
19 Separate audited financial statements of each subsidiary of the listed entity Yes https://www.panaceabiotec.com/en/section/information-repository/subsidiaries-financial-information
20 Secretarial compliance report Yes https://www.panaceabiotec.com/en/section/information-repository/secretarial-compliance-report
21 Materiality policy as per regulation 30 (4) Yes https://www.panaceabiotec.com/en/section/information-repository/policy
22 Disclosure of contact details of KMP who are authorized for the purpose of determining materiality as required under regulation 30(5) Yes https://media.panaceabiotec.com/other-important-information/2025/Investorscontact.pdf
23 Disclosures under regulation 30(8) Yes https://www.panaceabiotec.com/en/section/information-repository/corporate-announcement
24 Statements of deviation(s) or variations(s) as specified in regulation 32 NA
25 Dividend distribution policy as specified in regulation 43A (1) Yes https://media.panaceabiotec.com/policy/2021/Dividend%20Distribution%20Policy.pdf
26.1 Annual return as provided under section 92 of the Companies Act 2013 Yes https://www.panaceabiotec.com/en/section/information-repository/annual-return
26.2 Employee benefit scheme documents framed in terms of SEBI (SBEB) regulations 2021
27 Confirmation that the above disclosures are in a separate section as specified in regulation 46(2) Yes https://www.panaceabiotec.com/en/content/disclosures-under-regulation-46-of-sebi
28 Compliance with regulation 46(3) with respect to accuracy of disclosures on the website and timely updation Yes https://www.panaceabiotec.com/en/content/disclosures-under-regulation-46-of-sebi
29 Disclosure of notes on website in terms of Listing Regulations explanatory


Annexure II
II. Annual Affirmations
Sr Particulars Regulation Number Compliance status (Yes/No/NA) If status is No details of non-compliance may be given here.
1 Independent director(s) have been appointed in terms of specified criteria of independence and/or eligibility 16(1)(b) Yes
2 Board Composition 17(1), 17(1A) & 17(1C), 17(1D) & 17(1E) Yes
3 Meeting Of Board Of Directors 17(2) Yes
4 Quorum of board meeting 17(2A) Yes
5 Review of Compliance Reports 17(3) Yes
6 Plans for orderly succession for appointments 17(4) Yes
7 Code of Conduct 17(5) Yes
8 Fees/compensation 17(6) Yes
9 Minimum Information 17(7) Yes
10 Compliance Certificate 17(8) Yes
11 Risk Assessment & Management 17(9) Yes
12 Performance Evaluation of Independent Directors 17(10) Yes
13 Recommendation of Board 17(11) Yes
14 Maximum number of Directorships 17A Yes
15 Composition of Audit Committee 18(1) Yes
16 Meeting of Audit Committee 18(2) Yes
17 Role of Audit Committee and information to be reviewed by the audit committee 18(3) Yes
18 Composition of nomination & remuneration committee 19(1) & (2) Yes
19 Quorum of Nomination and Remuneration Committee meeting 19(2A) Yes
20 Meeting of Nomination and Remuneration Committee 19(3A) Yes
21 Role of Nomination and Remuneration Committee 19(4) Yes
22 Composition of Stakeholder Relationship Committee 20(1), 20(2) & 20(2A) Yes
23 Meeting of Stakeholders Relationship Committee 20(3A) Yes
24 Role of Stakeholders Relationship Committee 20(4) Yes
25 Composition and role of risk management committee 21(1),(2),(3),(4) Yes
26 Meeting of Risk Management Committee 21(3A) Yes
27 Quorum of Risk Management Committee meeting 21(3B) Yes
28 Gap between the meetings of the Risk Management Committee 21(3C) Yes
29 Vigil Mechanism 22 Yes
30 Policy for related party Transaction 23(1), (1A), (5), (6), & (8) Yes
31 Prior or Omnibus approval of Audit Committee for all related party transactions 23(2), (3) Yes
32 Approval for material related party transactions 23(4) Yes
33 Disclosure of related party transactions on consolidated basis 23(9) Yes
34 Composition of Board of Directors of unlisted material Subsidiary 24(1) Yes
35 Other Corporate Governance requirements with respect to subsidiary of listed entity 24(2),(3),(4),(5) & (6) Yes
36 Alternate Director to Independent Director 25(1) NA
37 Maximum Tenure 25(2) Yes
38 Appointment, Re-appointment or removal of an Independent Director through special resolution or the alternate mechanism 25(2A) Yes
39 Meeting of independent directors 25(3) & (4) Yes
40 Familiarization of independent directors 25(7) Yes
41 Declaration from Independent Director 25(8) & (9) Yes
42 Directors and Officers insurance 25(10) Yes
43 Confirmation with respect to appointment of Independent Directors who resigned from the listed entity 25(11) NA
44 Memberships in Committees 26(1) Yes
45 Affirmation with compliance to code of conduct from members of Board of Directors and Senior management personnel 26(3) Yes
46 Policy with respect to Obligations of directors and senior management 26(2) & 26(5) Yes
47 Approval of the Board and shareholders for compensation or profit sharing in connection with dealings in the securities of the listed entity 26(6) NA
48 Vacancies in respect Key Managerial Personnel 26A(1) & 26A(2), 26A(3) Yes
Any other information to be provided - Add Notes



Annexure II
III. Affirmations
Sr Particulars Compliance status (Yes/No/NA)
1 The Listed Entity has approved Material Subsidiary Policy and the Corporate Governance requirements with respect to subsidiary of Listed Entity have been complied Yes
Any other information to be provided



Annexure II
1 Name of signatory Ankit Jain
2 Designation Company Secretary and Compliance Officer



Additional Half yearly Disclosure
Any Other Information for Disclosure of Loans / Guarantees / Comfort Letters / Securities Etc.
I. Disclosure of Loans/ guarantees/comfort letters /securities etc.refer note below
(A)Any loan or any other form of debt advanced by the listed entity directly or indirectly to
Entity Aggregate amount advanced during six months Balance outstanding at the end of six months
Promoter or any other entity controlled by them
Promoter Group or any other entity controlled by them
Directors (including relatives) or any other entity controlled by them
KMPs or any other entity controlled by them
(B) Any guarantee / comfort letter (by whatever name called) provided by the listed entity directly or indirectly, in connection with any loan(s) or any other form of debt availed By
Entity Type (guarantee, comfort letter etc.) Aggregate amount of issuance during six months Balance outstanding at the end of six months(taking into account any invocation)
Promoter or any other entity controlled by them
Promoter Group or any other entity controlled by them
Directors (including relatives) or any other entity controlled by them
KMPs or any other entity controlled by them
(C) Any security provided by the listed entity directly or indirectly, in connection with any loan(s) or any other form of debt availed by
Entity Type of security (cash, shares etc.) Aggregate value of security provided during six months Balance outstanding at the end of six months
Promoter or any other entity controlled by them
Promoter Group or any other entity controlled by them
Directors (including relatives) or any other entity controlled by them
KMPs or any other entity controlled by them
(D) Additional Information
II. Affirmations
Affirmations Compliance Status Company Remarks
All loans (or other form of debt), guarantees, comfort letters (by whatever name called) or securities in connection with any loan(s) (or other form of debt) given directly or indirectly by the listed entity to promoter(s), promoter group, director(s) (including their relatives), key managerial personnel (including their relatives) or any entity controlled by them are in the economic interest of the company. $intratedCg.get("CG_YN_$!integratedFillingMasterDto.cgMasterVO.anx4aAffirmComplStatus")
Name
Designation
Place
Date



Signatory Details
Name of signatory Ankit Jain
Designation of person Company Secretary and Compliance Officer
Place New Delhi
Date 29-Apr-2026


Investor Grievance Details
No. of investor complaints pending at the beginning of Quarter 0
No. of investor complaints received during the Quarter 0
No. of investor complaints disposed off during the Quarter 0
No. of investor complaints those remaining unresolved at the end of the Quarter 0


Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies-
The details of acquisition of shares or voting rights in unlisted companies during the quarter in terms of sub-para 1 of para A of Part A of Schedule III are given below
Any Other Information for Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies
Sr. No. Name of the unlisted company in which shares or voting rights have been acquired Date of acquisition Aggregate holding (% shares or voting rights) as at the end of the previous quarter % shares or voting rights acquired during the quarter Aggregate holding (% shares or voting rights) as at the end of the quarter


Disclosure of Imposition of Fine or Penalty
The details of imposition of fine or penalty during the quarter in terms of sub-para 20 of para A of Part A of Schedule III are given below:
Any Other Information for Disclosure of Imposition of Fine or Penalty
Sr. No. Name of the authority Nature and details of the action(s) taken or order(s) passed Date of receipt of direction or order, including any ad interim or interim orders, or any other communication from the authority Details of the violation(s)/ contravention(s) committed or alleged to be committed Impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible


Disclosure of Updates to Ongoing Tax Litigations or Disputes
The updates on tax litigations or disputes in terms of sub-para 8 of para B of Part A of Schedule III read with corresponding provisions of Annexure 18 of the Master Circular are given below:

Any Other Information for Disclosure of Updates to Ongoing Tax Litigations or Disputes
Sr. No. Name of the opposing party Date of initiation of the litigation / dispute Status of the litigation / dispute as per last disclosure Current status of the litigation / dispute
1 Union of India represented through Commissioner of Central GST, Delhi East 08-Feb-2012 Show Cause Notice (SCN) dated 08-02-2012 for ₹12.94 million was issued by Commissioner of Central Excise Chandigarh alleging availment of ineligible CENVAT Credit. The Company filed a Writ Petition for quashing of SCN. Hon’ble High Court of Punjab and Haryana allowed Writ Petition vide Order dated 26-11-2019 and quashed the SCN. Union of India represented through Commissioner of Central GST, Delhi East preferred Special Leave Petition (SLP) before Hon’ble Supreme Court of India on 22-12-2020 against the High Court’s Order. The matter is pending before Hon'ble Supreme Court. No change during the quarter.
2 Deputy Commissioner of Income Tax, Central Circle-05, New Delhi 28-Mar-2012 Income tax demand of ₹162.22 million in respect to Assessment Year 2005-06 was raised by the Income Tax Department based on certain grounds related to purchases made by the Company from an overseas vendor. The matter was decided in favour of the Company and the addition of income was deleted by Commissioner of Income Tax (Appeals) (CIT (Appeals)). However, the Income Tax Department filed an appeal before Income Tax Appellate Tribunal (ITAT) against the order of CIT (Appeals). ITAT has vide its Order dated 27-02-2026, dismissed the appeal filed earlier by the Deputy Commissioner of Income Tax, New Delhi (DCIT) against the orders dated 24-07-2015 of CIT (Appeals) and quashed the assessment orders passed by the Assessing Officer for Assessment Year 2005-06.
3 Commissioner of Central GST, New Delhi 29-Jan-2015 Demand Order dated 29-01-2015 was issued by the Commissioner of Central Excise, Delhi raising demand of ₹62.50 million with penalty and interest of ₹8.10 million on account of non-payment of service tax u/s 68 on gross value of taxable services. The Company filed an appeal before Customs, Excise & Service Tax Appellate Tribunal, Delhi (“CESTAT”) against the said demand order which was allowed by CESTAT. However, Commissioner of Central GST, New Delhi preferred an appeal before the Hon'ble Delhi High Court (“DHC”) on 30-09-2020 which was rejected vide its order dated 10-09-2024. The said Commissioner then filed a Review Petition on 15-11-2024 before DHC against its order. The matter is pending before the Hon'ble Delhi High Court. No change during the quarter.
4 Deputy Commissioner of Income Tax, Central Circle-05, New Delhi 30-Mar-2015 A search operation was conducted by the Income Tax Department in the premises of the Company in January 2012 and hence the Company had re-filed the income tax returns for the Assessment Year 2006-07 to 2012-13. During the year ended March 31, 2015, the Income Tax Department completed the assessment of the said years, disallowed certain expenses on various grounds including purchases made from overseas party, FCCB raised, payment to overseas party and freebies given to doctors and issued demand of ₹3,294.90 million (including interest). The Company preferred appeals before the CIT (Appeals) against the orders of the Income Tax Department. The appeals were decided in favour of the Company and the demand was cancelled. However, CIT (Appeals) has made certain disallowances with respect to Assessment Year 2010-11 and 2011-12 against which the Company has filed appeals before the Income Tax Appellate Tribunal (ITAT). The Income Tax Department also filed appeals before ITAT against the orders of CIT (Appeals). ITAT has vide its Order dated 27-02-2026: dismissed the 7 appeals filed earlier by the Deputy Commissioner of Income Tax, New Delhi (DCIT) against the orders dated 24-07-2015 of CIT (Appeals) arising out of distinct assessment orders passed earlier by the Assessing Officer / DCIT, New Delhi for Assessment Years 2006-07 to 2012-13, respectively. allowed 2 appeals filed by the Company against the Orders dated 27-07-2015 of CIT Appeals arising out of Assessment Orders passed earlier by the Assessing Officer / DCIT for Assessment Years 2010-11 & 2011-12 respectively; and quashed the assessment orders passed by the Assessing Officer for Assessment Years 2006-07 to 2012-13.
5 Deputy Commissioner of Income Tax, Central Circle-05, New Delhi 30-Apr-2021 Demand of ₹33.69 million was raised by Income tax department vide its order dated 30-04-2021 on account of disallowance made by transfer pricing officer on purchases from / payment of expenses to, related parties in Assessment Year 2016-17. The Company filed an appeal before ITAT and case was decided in favour of the Company. Department filed an appeal against the ITAT order before the Hon'ble Delhi High Court. The appeal before the Hon'ble Delhi High Court is pending at present. No change during the quarter.
6 Deputy Commissioner of Income Tax, New Delhi 10-Oct-2023 Demand of ₹91.6 million was raised by Income Tax department vide its order dated 10-10-2023 on account of disallowance made by assessing officer in Assessment Year 2020-21. The Company filed an appeal before Commissioner of Income Tax (Appeals) (CIT(Appeals)) which was decided against the Company. The Company filed an appeal with ITAT. The appeal before ITAT is pending at present. No change during the quarter.
7 Office of Assistant Commissioner of State Tax, GST, Porur, Tamil Nadu 22-Feb-2025 Demand of ₹8.81 million was raised by GST Department vide its order dated 22-02-2025 in the name of Company's wholly owned subsidiary, Panacea Biotec Pharma Ltd. (PBPL), comprising of GST along with interest and penalty thereon, on account of claiming excess input tax credit in its GST returns for the FY 2020-21. PBPL filed an appeal against the said demand order on 20-05-2025 before the Deputy Commissioner of State Tax, Tamil Nadu. The appeal before the Deputy Commissoner of State Tax is pending. No change during the quarter.
8 Office of the State Tax Officer, Mazgaon, Mumbai, Maharashtra 25-Feb-2025 Demand of ₹15.82 million was raised by GST Department vide its order dated 25-02-2025 in the name of PBPL, comprising of GST along with interest and penalty thereon, on account of claiming excess input tax credit in its GST return for the FY 2020-21. PBPL filed an appeal against the said demand order on 16-05-2025 before the Deputy Commissioner of State Tax, Maharashtra. Order dated 10-03-2026 has been received from Deputy Commissioner of State Tax, Maharashtra reducing total demand from ₹15.82 million to ₹8.15 million. The Company is taking the necessary steps as may be considered appropriate including filing an appeal before the appropriate authority.
9 Office of the Assistant Commissioner of State Tax, GST Bhawan, Mazgaon, Mumbai, Maharashtra 10-Jul-2025 Demand Order dated 10-07-2025 of ₹70.34 million was received from the Assistant Commissioner of State Tax, Mumbai towards balance amount of Goods and Service Tax (GST) (including interest & penalty thereon) on assignment of leasehold rights in land and building by the Company in Navi Mumbai. The Company filed writ petition before the Hon’ble Bombay High Court, challenging the said Order on 04-09-2025. The Hon'ble High Court has issued an interim order dated 25-02-2026 pursuant to which the authority has been directed that pending the hearing and final disposal of the petition, no recovery under the impugned orders shall be adopted against the Company. The matter is pending before the Hon'ble Bombay High Court.
10 Office of the Commissioner, Central GST (Audit) Commissionerate, Punjab 26-Sep-2025 Show cause notice (SCN) was issued under the Central Goods and Services Tax Act, 2017 (CGST Act) regarding alleged non-payment of GST of ₹114.40 million on providing Corporate Guarantee amounting to ₹8,640 million to Debenture Trustee viz. Vistra ITCL (India) Limited in relation to transfer of pharmaceutical formulations business to the Company’s wholly owned subsidiary viz. Panacea Biotec Pharma Limited, for 1,074 days from 06-04-2019 to 15-03-2022. The Company filed writ petition before the Hon’ble Punjab & Haryana High Court on 24-11-2025, challenging the said Order. The Hon'ble High Court has passed an interim stay order stating inter-alia that no coercive action be taken against the Company in case of final assessment order is passed or a demand is raised. In the meantime, Joint Commissioner, CGST Sub-Commissionerate Mohali, Chandigarh has issued a Demand Order dated 30-03-2026 raising demand aggregating to ~₹228.80 million (towards alleged non-payment of GST of ~₹114.40 million and penalty of ~₹114.40 million). The Company is taking the necessary steps as may be considered appropriate.
11 Assistant Commissioner of Income Tax, New Delhi 24-Dec-2025 Demand aggregating to ₹93.88 million was raised by Income Tax department vide its three Demand Orders dated 24-12-2025, imposing penalty on account of alleged under reporting of income. The Company filed appeals with Commissioner of Income Tax (Appeals) (CIT(A)) against the said Demand Order. The CIT(A) has dismissed the appeals vide its order dated 25-03-2026. The Company is taking necessary steps including filing an appeal with appellate authority against the said Order of the CIT(A).
12 Deputy Commissioner of Income Tax, New Delhi 27-Feb-2026 Demand of ₹457.14 million (including interest) was raised by Deputy Commissioner of Income Tax, New Delhi (DCIT) vide its Demand Order dated 27-02-2026, on account of additions made in the Assessment Order for Assessment Year 2015-16. The Company has noticed errors specifically relating to double addition of disallowances and the omission of set-off for brought-forward losses. Accordingly, the Company has filed a rectification application on 12-03-2026 under Income Tax Act, 1961 (“Act”) to correct such errors. DCIT issued a rectified Assessment Order dated 06-04-2026 wherein the said errors have been corrected, and the Company’s tax liability for AY 2015-16 has been determined as Nil. Accordingly, the matter is now closed.
13 Deputy Commissioner of Income Tax, New Delhi 01-Mar-2026 Demand of ₹102.39 million (including interest) was raised by Deputy Commissioner of Income Tax, New Delhi (DCIT) vide its Demand Order dated 01-03-2026, on account of additions made in the Assessment Order for Assessment Year 2016-17. The Company has noticed errors specifically relating to double addition of disallowances and the omission of set-off for brought-forward losses. Accordingly, the Company has filed a rectification application on 12-03-2026 under Income Tax Act, 1961 (“Act”) to correct such errors. DCIT issued a rectified Assessment Order dated 06-04-2026 wherein the said errors have been corrected, and the Company’s tax liability for AY 2016-17 has been determined as Nil. Accordingly, the matter is now closed.